Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

, randomized phase 3 trial comparing the experimental combination therapy and standard of care intravesical BCG therapy.

intravesical bcg
carcinoma in situ
gemcitabine
bladder cancer
docetaxel
  • 2 views
  • 17 Sep, 2021
  • 1 location
Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

This prospective study aims at using Artificial intelligence to create a helpful unbiased machine learning-based model that predicts BCG unresponsiveness in high risk BCG-naïve NMIBC patients incorporating all potential clinico-pathological, radiological and/or molecular prognostic factors.

  • 0 views
  • 05 May, 2022
  • 1 location